Oncology Researchers Awarded DHT Summer Studentships
News Jul 01, 2013
The DHT scheme, now in its second year, enables undergraduates to extend their studies over the summer period by gaining practical lab experience, using non-animal approaches, that will further our understanding of devastating diseases.
Each award is worth up to £1,440 over a maximum 8 week period, with a separate budget of up to £500 available for consumables.
Professor Blair’s student, Jonathan Carr, who is studying for a BSc in Medical Biochemistry, will extend his studies by gaining practical laboratory experience to understand whether human adenoviruses can enter, spread and migrate through a multi-cellular tumour spheroid and whether this process can be monitored in real time using live cell imaging techniques.
Professor Hanemann’s student, Jade Lyons-Rimmer, who is studying for a BSc in Clinical Sciences, will aim to identify novel binding partners of KSR1 in human Schwann cells using a proteomics-based approach to further understand the roles of KSR1 in proliferation and apoptosis of Schwann cells. This project offers exciting replacement potential and this non-animal approach alone will prevent approximately 190 mice being used.
Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “Our Summer Studentship award is an opportunity to inspire the next generation of research students.
“We are really encouraged by the quality and quantity of the entries we have received this year. The winners of our awards clearly demonstrated how their animal-alternative research techniques had the potential to replace the use of many animals in conventional biomedical research.
"We are confident that the projects chosen will deliver not only valuable science but whet an appetite in these students to continue this work long after they graduate."
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018
EMBL Course: Techniques for Mammary Gland Research
Mar 05 - Mar 09, 2018